IMPROVE sugar: improving outcomes for diabetes in Indigenous Australians in regional and remote communities — implementation of a novel intensive lifestyle and therapeutic model of care.
The aim of this study is to evaluate the safety, feasibility, and efficacy of an intensive model of diabetes care involving weekly clinic attendance for the administration of tirzepatide (once weekly injectable glucose lowering agent) and close monitoring of glucose control, compared with usual care and prescription of tirzepatide in Aboriginal and Torres Strait Island patients with inadequately controlled type 2 diabetes living in regional and remote communities. This national trial will include 10 randomised communities, with 26 participants from each community.